SOP Status epilepticus bei Erwachsenen

Der Status epilepticus ist ein häufiger neurologischer Notfall. Trotz erheblicher Fortschritte in der Notfall- und Intensivmedizin in den letzten Jahren ist der Status epilepticus weiterhin mit einer hohen Mortalität assoziiert. Wichtige Faktoren für die erfolgreiche Status-epilepticus-Therapie ist neben der Kenntnis und Umsetzung von leitliniengerechten Therapiealgorithmen vor allem die ausreichend hoch dosierte Benzodiazepingabe in der Initialphase.

Schlüsselwörter

Epilepsie - Notfallmedizin - Benzodiazepin - neurologischer Notfall

Publikationsverlauf

Artikel online veröffentlicht:
02. September 2025

• Literatur

• 1 Leitinger M, Trinka E, Giovannini G. et al. Epidemiology of status epilepticus in adults: a population-based study on incidence, causes, and outcomes. Epilepsia 2019; 60: 53-62
• 2 Neligan A, Noyce AJ, Gosavi TD. et al. Change in mortality of generalized convulsive status epilepticus in high-income countries over time: a systematic review and meta-analysis. JAMA Neurol 2019; 76: 897-905
• 3 Rosenow F, Weber J. et al. Status epilepticus im Erwachsenenalter, S2k-Leitlinie. Leitlinien für Diagnostik und Therapie in der Neurologie. 2020 Zugriff am 06. August 2025 unter: https://www.dgn.org/leitlinien
• 4 Jungilligens J, Michaelis R, Popkirov S. Misdiagnosis of prolonged psychogenic non-epileptic seizures as status epilepticus: epidemiology and associated risks. J Neurol Neurosurg Psychiatry 2021; 92: 1341-1345
• 5 Bauer G, Trinka E. Nonconvulsive status epilepticus and coma. Epilepsia 2010; 51: 177-190
• 6 Leitinger M, Beniczky S, Rohracher A. et al. Salzburg consensus criteria for non-convulsive status epilepticus – approach to clinical application. Epilepsy Behav 2015; 49: 158-163
• 7 DeLorenzo RJ, Waterhouse EJ, Towne AR. et al. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia 1998; 39: 833-840
• 8 Kellinghaus C, Rossetti AO, Trinka E. et al. Factors predicting cessation of status epilepticus in clinical practice: data from a prospective observational registry (SENSE). Ann Neurol 2019; 85: 421-432
• 9 Silbergleit R, Durkalski V, Lowenstein D. et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 2012; 366: 591-600
• 10 Kay L, Merkel N, von Blomberg A. et al. Intranasal midazolam as first-line inhospital treatment for status epilepticus: a pharmaco-EEG cohort study. Ann Clin Transl Neurol 2019; 6: 2413-2425
• 11 Kapur J, Elm J, Chamberlain JM. et al. Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med 2019; 381: 2103-2113
• 12 Hawkes MA, Eliliwi M, Wijdicks EFM. The origin of the burst-suppression paradigm in treatment of status epilepticus. Neurocrit Care 2024; 40: 849-854
• 13 Musialowicz T, Mervaala E, Kalviainen R. et al. Can BIS monitoring be used to assess the depth of propofol anesthesia in the treatment of refractory status epilepticus?. Epilepsia 2010; 51: 1580-1586
• 14 Muhlhofer WG, Layfield S, Lowenstein D. et al. Duration of therapeutic coma and outcome of refractory status epilepticus. Epilepsia 2019; 60: 921-934
• 15 Bellante F, Legros B, Depondt C. et al. Midazolam and thiopental for the treatment of refractory status epilepticus: a retrospective comparison of efficacy and safety. J Neurol 2016; 263: 799-806
• 16 Rossetti AO, Milligan TA, Vulliemoz S. et al. A randomized trial for the treatment of refractory status epilepticus. Neurocrit Care 2011; 14: 4-10
• 17 Claassen J, Taccone FS, Horn P. et al. Recommendations on the use of EEG monitoring in critically ill patients: consensus statement from the neurointensive care section of the ESICM. Intensive Care Med 2013; 39: 1337-1351
• 18 Delaj L, Novy J, Ryvlin P. et al. Refractory and super-refractory status epilepticus in adults: a 9-year cohort study. Acta Neurol Scand 2017; 135: 92-99
• 19 Thakur KT, Probasco JC, Hocker SE. et al. Ketogenic diet for adults in super-refractory status epilepticus. Neurology 2014; 82: 665-670
• 20 Cervenka MC, Hocker S, Koenig M. et al. Phase I/II multicenter ketogenic diet study for adult superrefractory status epilepticus. Neurology 2017; 88: 938-943
• 21 Gaspard N, Foreman B, Judd LM. et al. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia 2013; 54: 1498-1503
• 22 Hofler J, Rohracher A, Kalss G. et al. (S)-Ketamine in refractory and super-refractory status epilepticus: a retrospective study. CNS Drugs 2016; 30: 869-876
• 23 Stetefeld HR, Schaal A, Scheibe F. et al. Isoflurane in (super-) refractory status epilepticus: a multicenter evaluation. Neurocrit Care 2021; 35: 631-639
• 24 Legriel S, Lemiale V, Schenck M. et al. Hypothermia for neuroprotection in convulsive status epilepticus. N Engl J Med 2016; 375: 2457-2467